Nodthera Shows Oral NLRP3 Inhibitor Reverses Parkinson’s Inflammation
August 12, 2025
NodThera Demonstrates Reversal of Neuroinflammation and Inflammation in Parkinson’s Disease with Oral NLRP3 Inhibitor NodThera, a biotech company that’s in the clinical stage, is focused